Therapy News and Research

RSS

Alivio Therapeutics receives DoD grant to advance development of new therapy for IC/BPS

Alivio Therapeutics, an affiliate of PureTech Health plc developing therapies to treat inflammatory disorders through targeted disease immunomodulation, today announced a $3.3 million U.S. Department of Defense Technology/Therapeutic Development Award to advance Alivio's product candidate, ALV-107, for the treatment of interstitial cystitis/bladder pain syndrome with Hunner's lesions.

12 Sep 2018

Researchers design new medicine to treat highly aggressive pancreatic cancer

A treatment for highly aggressive and commonly fatal pancreatic cancer is being developed, reports a University of Houston researcher who has designed a new medicine that can inhibit two of the major pathways of the deadly disease.

12 Sep 2018

Researchers untangle mysteries of 'evil' protein in ER-positive breast cancer

Breast cancer is one of the most common cancers in the United States, striking 1 out of 8 women. About 80 percent of all breast cancers are estrogen receptor-positive, in which cancer growth is fueled by estrogen.

12 Sep 2018

Using stem cells extracted from baby teeth to regrow dental tissues

Sometimes kids trip and fall, and their teeth take the hit. Nearly half of children suffer some injury to a tooth during childhood. When that trauma affects an immature permanent tooth, it can hinder blood supply and root development, resulting in what is essentially a "dead" tooth.

12 Sep 2018

Treating sleep apnea in stroke patients provides significant benefits

A large study has found that commencing treatment for sleep apnea as soon as possible after a stroke or a mini-stroke significantly improves speech impairment and other neurological symptoms as well as walking and other physical functioning.

11 Sep 2018

Artificial anti-oxidant is up to 100 times more powerful than nature's best

Naturally-derived anti-oxidants have become the 'it' health ingredient to look for in food. But researchers from UBC Okanagan and the University of Bologna have discovered that TEMPO--a well-known artificial anti-oxidant--is up to 100 times more powerful than nature's best and could help counteract everything from skin damage to Alzheimer's Disease.

11 Sep 2018

ImmusanT receives JDRF T1D Fund to develop novel vaccine candidate for type 1 diabetes

ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy™ platform to translate and deliver first-in-class peptide-based immune therapies to people living with autoimmune diseases, today announced that it has received an investment from the JDRF T1D Fund, a venture philanthropy fund exclusively devoted to finding and funding the best type 1 diabetes commercial opportunities.

11 Sep 2018

Gene involved in circadian rhythms can be potential target for glioblastoma treatment

Scientists with the Virginia Tech Carilion Research Institute say a gene involved in the body's circadian rhythms is a potential target for therapies to help patients with a deadly form of brain cancer known as glioblastoma.

11 Sep 2018

Mechanically ventilated patients treated with vasopressor may develop ICU-related weakness

At least 25 percent of critically ill patients who receive mechanical ventilation in intensive care units develop muscular weakness severe enough to impair their quality of life.

11 Sep 2018

Effects of cancer-causing KRAS mutations more diverse than thought, shows study

The effects of KRAS mutations underlying many different types of cancer are more diverse than previously thought, according to a new study led by the University of Eastern Finland.

11 Sep 2018

Study aims to understand role of clopidogrel in patients with cardiovascular disease

Platelet inhibition with aspirin is the cornerstone of medical therapy for coronary artery disease. In the era of percutaneous coronary intervention with drug-eluting stents, dual anti-platelet therapy with the addition of clopidogrel became the mainstay of therapy.

11 Sep 2018

Functional Family Therapy may not be effective in tackling behavioral problems in young people

A long-established treatment used around the world to help troubled young people and their families tackle behavioral problems may not be as effective as its practitioners claim - a new study reveals.

11 Sep 2018

New issue considers role of coronary angiography after cardiac arrest

Coronary angiography after cardiac arrest is important to ascertain potential treatable causes of cardiac arrest, salvage myocardium, and potentially increase long-term survival. The cause of adult out-of-hospital cardiac arrest is typically myocardial ischemia.

11 Sep 2018

Barrow Institute initiates $50 million effort to seek cure for glioblastoma

Barrow Neurological Institute has initiated a $50 million effort, supported by the single largest research grant in the history of brain tumor research, to seek a cure for the deadliest form of brain cancer.

11 Sep 2018

Kessler Foundation awarded $50,000 grant to study outcomes of new stroke therapy

Kessler Foundation has been awarded a $50,000 grant by the Charles and Ann Serraino Foundation, Inc. The two-year grant will advance the Foundation's practice-based stroke rehabilitation research to advance the diagnosis and treatment of spatial neglect, a hidden disability that complicates recovery after brain injury, especially right brain stroke.

11 Sep 2018

Medical cannabis provides relief across dozens of health symptoms, study shows

Utilizing new mobile application technology, researchers at The University of New Mexico found that medical cannabis provides immediate symptom relief across dozens of health symptoms with relatively minimal negative side effects.

11 Sep 2018

Researchers examine Twitter conversations to understand thoughts concerning OpenAPS technology

The diabetes online community is leading grassroots efforts focused on accelerating the development, access and adoption of diabetes-related tools to manage the disease.

11 Sep 2018

CRI to bestow top honors on three scientists for contributions to cancer immunology and immunotherapy

The Cancer Research Institute, a nonprofit organization dedicated to the discovery and development of immunotherapies for all forms of cancer, will bestow its highest honors on three scientists who have made fundamental contributions to the fields of immunology and cancer immunotherapy.

11 Sep 2018

Researchers identify new cancerous cells responsible for acute myeloid leukemia relapse

McMaster University researchers have provided evidence of new cancerous cells they have termed cancer regenerating cells, which are responsible for the return of acute myeloid leukemia after remission.

10 Sep 2018

New screening strategy identifies novel inhibitors that may help develop cure for Parkinson's

Parkinson's disease is the most common movement disorder in the world. PD patients suffer from shaking, rigidity, slowness of movement and have difficulties walking.

10 Sep 2018

Therapy News and Research

Alivio Therapeutics receives DoD grant to advance development of new therapy for IC/BPS

Researchers design new medicine to treat highly aggressive pancreatic cancer

Researchers untangle mysteries of 'evil' protein in ER-positive breast cancer

Using stem cells extracted from baby teeth to regrow dental tissues

Treating sleep apnea in stroke patients provides significant benefits

Artificial anti-oxidant is up to 100 times more powerful than nature's best

ImmusanT receives JDRF T1D Fund to develop novel vaccine candidate for type 1 diabetes

Gene involved in circadian rhythms can be potential target for glioblastoma treatment

Mechanically ventilated patients treated with vasopressor may develop ICU-related weakness

Effects of cancer-causing KRAS mutations more diverse than thought, shows study

Study aims to understand role of clopidogrel in patients with cardiovascular disease

Functional Family Therapy may not be effective in tackling behavioral problems in young people

New issue considers role of coronary angiography after cardiac arrest

Barrow Institute initiates $50 million effort to seek cure for glioblastoma

Kessler Foundation awarded $50,000 grant to study outcomes of new stroke therapy

Medical cannabis provides relief across dozens of health symptoms, study shows

Researchers examine Twitter conversations to understand thoughts concerning OpenAPS technology

CRI to bestow top honors on three scientists for contributions to cancer immunology and immunotherapy

Researchers identify new cancerous cells responsible for acute myeloid leukemia relapse

New screening strategy identifies novel inhibitors that may help develop cure for Parkinson's

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News